Post by
steadfast on Dec 13, 2020 2:27pm
We can forget SVA listing on Nasdaq
SVA do not meet any of the 4 Standard Requirements. Mgt must concentrate on
getting an IR firm that can get the share price to equal a mkt cap close to $750M US min.
Pharma's are not going to offer $1B U.S. on a $1 Can stock .
We meed a Mkt Cap of around $ 750M U.S. for them to pay a 30% premium.
YEs, looking at Semma & Sigilon we should be at least $1B U.S.
The Momentum is here now, Bioteck stocks are HOT.
The Bull Market is still intact, we need to move now before the Crash comes.
Comment by
eunice12 on Dec 30, 2020 11:04am
steadfast ly stupid wrote "We meed a Mkt Cap of around $ 750M U.S. for them to pay a 30% premium." I'm doubting you know how acquire a pubco since you think it is always a mathematical multiple of sp. It is all about the value that the acquisition company can bring coupled with what the acquirer can pick it up at - neither of which you know.
Comment by
Metalsguy1 on Dec 30, 2020 12:08pm
spot on Eunice. A buyout comes at whatever price a company is willing to pay. Aside from that the most likely scenarios for a buyout if substantive starts flowing are 1) somebody writes a check that starts a bidding war or 2) somebody writes a check that just blindsides and knocks out the competition. Otherwise, we just ride the news waves.